Buy, Sell, Hold: CoreWeave Near $100 Sparks Debate
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesCoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
A patient fund boosted its stake by roughly $7 million in a major packaging company even though the stock trailed the...
A surge of quantum milestones in 2026 is fueling talk that could commercially useful quantum machines may arrive soon...
A seasoned investor quietly built a multi-million stake in a fast-moving chemicals firm. This article breaks down the...
GameStop’s walking away from a massive pay package marks a dramatic pivot as the company uses its stock to press a bi...
Deeptune raises $43 million in a Series A led by Andreessen Horowitz to build immersive training gyms for AI agents. ...
Solstice and TensorX unveil a financing pact to fund up to $1 billion in European sovereign AI infrastructure, using ...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
The (PPL) 2026 earnings call offers clues on dividend stability, capital plans, and regulatory risk. This guide trans...
Bill Maher accepts the Mark Twain Prize at the Kennedy Center, a night that blends comedy with urgent questions about...
Are you weighing a Roth IRA conversion? This guide highlights three signals that 2026 could perfect your move, plus a...